Utility of Two PANSS 5-Factor Models for Assessing Psychosocial Outcomes in Clinical Programs for Persons with Schizophrenia

Table 1

Descriptive comparison at baseline.

Independent variable	Total (𝑁=108)	Olanzapine (𝑁=30)	Risperidone (𝑁=36)	Conventional (𝑁=42)	𝑃 value*
Ethnicity: nonwhite	79 (73.1)	19 (63.3)	28 (77.8)	32 (76.2)	0.36
Gender: male	68 (63.0)	17 (56.7)	23 (63.9)	28 (66.7)	0.68
Diagnosis: schizoaffective disorder	36 (33.3)	12 (40.0)	11 (30.6)	13 (31.0)	0.66
Education level: <high school	70 (64.8)	20 (66.7)	23 (63.9)	27 (64.3)	0.97
Age	36.9±8.8	34.1±9.3	37.6±9.2	38.4±7.6	0.11
24 hr care days in past 6 months	12.6±19.0	19.8±25.3	11.1±18.5	8.7±11.9	0.04
Prior inpatient admissions	9.8±8.2	9.4±8.2	9.1±7.6	10.5±8.7	0.74
Taking anticholinergic meds	72 (66.7)	17 (56.7)	24 (66.7)	31 (73.8)	0.31

∗Data shown are 𝑁 (%) or mean ± SD.